13 research outputs found
CV5 THE COSTS AND EFFECTS OF CLOPIDOGREL IN COMPARISON TO ASA OR PLACEBO FOR SEVERAL PATIENT POPULATIONS IN DENMARK
Get PDF
Public health economics of vaccines in the Netherlands: methodological issues and applications
Get PDF
PIN27 COST-EFFECTIVENESS ANALYSIS OF CASPOFUNGIN VERSUS AMPHOTERICIN B, VORICONAZOLE, AND ANIDULAFUNGIN IN THE TREATMENT OF INVASIVE CANDIDIASIS
No full textPMC11 DEALING WITH COMPETING CAUSES OF DEATH, ILLNESS AND COSTS:THE DISEASE ELIMINATION LIFE TABLE ANALYSIS (DELTA) MODEL
No full textPIN41 DEVELOPING AN ECONOMIC MODEL OF GRAM+ COMPLICATED SKIN AND SOFT TISSUE INFECTIONS (CSSTI) FOR INPATIENT AND OUTPATIENT TREATMENT SETTINGS
No full textPDB33 COST EFFECTIVENESS OF JANUVIA VERSUS AVANDIA AS SUPPLEMENTARY TREATMENT IN COMBINATION WITH METFORMIN FOR PATIENTS WITHTYPE 2 DIABETES
No full textPHM17 RECOMBINANT ACTIVATED FACTOR VII (RFVIIA)VS. ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE (APCC) FOR ON-DEMAND TREATMENT OF JOINT BLEEDS IN HEMOPHILIACS WITH INHIBITORS: A SYSTEMATIC REVIEW AND BAYESIAN META-REGRESSION SURVIVAL MODEL WITH TIME-DEPENDENT COVARIATES
No full text
